United States Cellular Corporat (UZE)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

United States Cellular Corporat (UZE) is down 1.1% since the beginning of the year. At $17 per share, UZE is trading 24.1% below its 52-week high of $22. Investors who bought $1,000 worth of UZE shares 5 years ago would now be looking at an investment worth $952.

United States Cellular Corporat (UZE) has returned -1.10% so far this year and -16.59% over the past 12 months.

Based on dividend-adjusted daily data since Dec 15, 2020, UZE's average daily return is +0.01%, while the average monthly return is +0.28%. At this rate, an investment would double in approximately 20.7 years.

Historically, 51% of months were positive and 49% were negative. The best month was Jan 2023 with a return of +27.8%, while the worst month was Aug 2025 at -19.5%. The longest winning streak lasted 8 consecutive months, and the longest losing streak was 5 months.

On a daily basis, UZE closed higher 48% of trading days. The best single day was May 28, 2024 with a return of +18.1%, while the worst single day was Aug 11, 2025 at -7.2%.

United States Cellular Corporat has an annualized alpha of -3.66%, beta of 0.44, and R2 of 0.09 versus S&P 500 Index. Calculated based on daily prices since December 16, 2020.

• This stock participated in 79.75% of S&P 500 Index downside but only 35.52% of its upside - more exposed to losses than it benefited from rallies.
• Beta of 0.44 may look defensive, but with R2 of 0.09 this stock is largely uncorrelated with S&P 500 Index - low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R2 of 0.09 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

UZE ranks 10 for risk / return — in the bottom 10% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.

The table below present risk-adjusted performance metrics for United States Cellular Corporat (UZE) and compare them to S&P 500 Index.

United States Cellular Corporat provided a 8.11% dividend yield over the last twelve months, with an annual payout of $1.38 per share.

The table displays the monthly dividend distributions for United States Cellular Corporat. The dividends shown in the table have been adjusted to account for any splits that may have occurred.

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the United States Cellular Corporat. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the United States Cellular Corporat was 48.42%, occurring on May 16, 2023. Recovery took 338 trading sessions.

The current United States Cellular Corporat drawdown is 17.41%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of United States Cellular Corporat over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how United States Cellular Corporat is priced in the market compared to other companies in the undefined industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.